Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-20

Clinical Trial Update: An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT

View source ↗

Summary

An observational pharmacokinetic study evaluating ceftolozane-tazobactam in ICU patients with and without CRRT; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ceftolozane/Tazobactam (ceftolozane/tazobactam)

Snippet

Sponsor: Royal Brisbane and Women's Hospital | Conditions: Gram-Negative Bacterial Infections | Status: COMPLETED | Results posted: 2019-09-20